135716-16-4

Basic information

• Product Name: (S)-2-Methyl-butyric acid (1S,3R,4aS,7S,8S,8aS)-8-(2-{(4R,6S)-6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-2,2-dimethyl-[1,3]dioxan-4-yl}-ethyl)-3-hydroxy-7-methyl-decahydro-naphthalen-1-yl ester
• CAS NO: 135716-16-4
• Molecular Weight: 693.052
• Mol File: 135716-16-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-2-Methyl-butyric acid (1S,3R,4aS,7S,8S,8aS)-8-(2-{(4R,6S)-6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-2,2-dimethyl-[1,3]dioxan-4-yl}-ethyl)-3-hydroxy-7-methyl-decahydro-naphthalen-1-yl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-Methyl-butyric acid (1S,3R,4aS,7S,8S,8aS)-8-(2-{(4R,6S)-6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-2,2-dimethyl-[1,3]dioxan-4-yl}-ethyl)-3-hydroxy-7-methyl-decahydro-naphthalen-1-yl ester(135716-16-4)
• EPA Substance Registry System: (S)-2-Methyl-butyric acid (1S,3R,4aS,7S,8S,8aS)-8-(2-{(4R,6S)-6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-2,2-dimethyl-[1,3]dioxan-4-yl}-ethyl)-3-hydroxy-7-methyl-decahydro-naphthalen-1-yl ester(135716-16-4)

Safety Data

• Hazardous Substances Data: 135716-16-4(Hazardous Substances Data)

Upstream product

• 133805-99-9 (S)-2-Methyl-butyric acid (1S,3S,7S,8S,8aR)-3-(tert-butyl-dimethyl-silanyloxy)-8-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester 
• 136598-11-3 (S)-2-Methyl-butyric acid (1S,3R,4aS,7S,8S,8aS)-3-hydroxy-8-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-decahydro-naphthalen-1-yl ester 
• 136491-72-0 (S)-2-Methyl-butyric acid (1S,3R,4aS,7S,8S,8aS)-3-hydroxy-7-methyl-8-((3R,5S)-3,5,7-trihydroxy-heptyl)-decahydro-naphthalen-1-yl ester 
• 85956-22-5 pravastatin lactone 
• 81093-37-0 pravastatin 
• 135716-15-3 (S)-2-Methyl-butyric acid (1S,3R,4aS,7S,8S,8aS)-8-[(3R,5S)-7-(tert-butyl-diphenyl-silanyloxy)-3,5-dihydroxy-heptyl]-3-hydroxy-7-methyl-decahydro-naphthalen-1-yl ester 
• 67-64-1 acetone 

Downstream Products

• 136491-73-1 (S)-2-Methyl-butyric acid (1S,4aS,7S,8S,8aS)-8-(2-{(4R,6S)-6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-2,2-dimethyl-[1,3]dioxan-4-yl}-ethyl)-7-methyl-3-oxo-decahydro-naphthalen-1-yl ester 

Relevant articles and documents

Synthetic transformations of the mevinic acid nucleus: Preparation of a monocyclic analogue of compactin

The synthetic transformation of pravastatin into a fully functional, monocyclic analogue of compactin via a multistep sequence is described.